Andere Sprachen Biotest AG

Aktien

522723

DE0005227235

BIO3

Realtime-Estimate Tradegate Andere Börsenplätze 13:30:00 28.06.2024			% 5 Tage	% 1. Jan.
26.5 ^EUR	+0.38%		-3.30%	-14.84%

17.06.	Biotest erhält FDA-Zulassung für innovatives Yimmugo-Immunglobulin zur Behandlung primärer Immundefekte	CI
07.05.	Biotest Aktiengesellschaft meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Biotest : Rules of Procedure of the Supervisory Board PDF, 184 KB	24.06.
Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds'	24.06.
Biotest Receives FDA Approval for Innovative Yimmugo Immunoglobulin to Treat Primary Immunodeficiencies	17.06.
Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo	17.06.
Biotest : Speech of Peter Janssen - German Version	08.05.
Biotest AG: Annual General Meeting approves dividend distribution	07.05.
Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024	07.05.
Biotest Launches New Plasma Collection Center in Germany	19.04.
Biotest AG opens 12th plasma collection centre in Germany	19.04.
Biotest AG increased sales by 32% in the financial year 2023	28.03.
Biotest : Sustainability report Declaration of compliance 2023	28.03.
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Biotest : Invitation / Agenda of Annual General Meeting 2024	26.03.
Biotest : Notes on agenda item 1 - German Version	25.03.
Biotest achieves EBIT forecast for 2023	29.02.
Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care	28.02.
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate	14.02.
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	30.01.
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	22.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biotest AG

Aktien

522723

DE0005227235

BIO3

Andere Sprachen

Filter